DECLARE-TIMI 58 trial in the context of EMPA-REG OUTCOME and CANVAS

por Marina V. Shestakova
Publicado 2019

Review of the results of the EASYDia international observational study. The effect of dose titration of diabeton MR on the effectiveness of treatment of type 2 diabetes

por Natalia Р. Trubitsyna, Marina V. Shestakova
Publicado 2019

Once-weekly administration of dulaglutide, a glucagon-like peptide-1 receptor agonist, as monotherapy and combination therapy: review of the AWARD studies

por Marina V. Shestakova, Ekaterina A. Yudovich
Publicado 2017

Prognostic factors for the carbohydrate metabolism normalization in patients with type 2 diabetes mellitus and obesity using liraglutide 3.0 mg per day

por Igor A. Sklyanik, Marina V. Shestakova
Publicado 2021

Sakharnyy diabet i endotelial'naya disfunktsiya

por Ivona Renata Yarek-Martynova, Marina V. Shestakova
Publicado 2004

The new views on the state of the gut microbiota in obesity and diabetes mellitus type 2

por Elena V. Pokrovskaya, Minara S. Shamkhalova, Marina V. Shestakova
Publicado 2019

Corrigendum: The new views on the state of the gut microbiota in obesity and diabetes mellitus type 2 (Diabetes mellitus. 2019;22(3). doi: 10.14341/DM10194)

por Elena V. Pokrovskaya, Minara S. Shamkhalova, Marina V. Shestakova
Publicado 2019

A review of insulin lispro for the treatment of patients with type 2 diabetes mellitus

por Marina V. Shestakova, Svetlana V. Elizarova, Abdul Jabbar
Publicado 2016

Nephroprotective potential of glucagon-like peptide-1 receptor agonists

por Minara S. Shamkhalova, Igor A. Sklyanik, Marina V. Shestakova
Publicado 2020

The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study)

por Ivan I. Dedov, Marina V. Shestakova, Gagik R. Galstyan
Publicado 2016

The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice

por Galina A. Melnichenko, Marina V. Shestakova, Roman V. Rozhivanov
Publicado 2019

Course and treatment of diabetes mellitus in the context of COVID-19

por Marina V. Shestakova, Natalya G. Mokrysheva, Ivan I. Dedov
Publicado 2020

The clinical and epidemiological characteristics of hypogonadism in men with type 2 diabetes mellitus

por Galina A. Mel'nichenko, Marina V. Shestakova, Roman V. Rozhivanov
Publicado 2019

Urate-lowering effects of dipeptidyl peptidase-4 inhibitors

por Taras S. Panevin, Olga V. Zhelyabina, Maxim S. Eliseev, Marina V. Shestakova
Publicado 2020

Clinical, pathomorphological and immunohistochemical evaluation of tissue repair in diabetic foot ulcers

por Alla Y. Tokmakova, Ekaterina L. Zaitseva, Iya A. Voronkova, Marina V. Shestakova
Publicado 2018

Classification of diabetes. World Health Organization 2019. What’s new?

por Irina V. Kononenko, Olga M. Smirnova, Aleksandr Y. Mayorov, Marina V. Shestakova
Publicado 2020

Type 2 diabetes and prediabetes prevalence in patients with different risk factor combinations in the NATION study

por Ekaterina A. Shestakova, Elena Y. Lunina, Gagik R. Galstyan, Marina V. Shestakova, Ivan I. Dedov
Publicado 2020

Diabetes mellitus in Russian Federation: prevalence, morbidity, mortality, parameters of glycaemic control and structure of glucose lowering therapy according to the Federal Diabet...

por Ivan I. Dedov, Marina V. Shestakova, Olga K. Vikulova, Anna V. Zheleznyakova, Michail А. Isakov
Publicado 2018

Atlas of Diabetes Register in Russian Federation, status 2018

por Ivan I. Dedov, Marina V. Shestakova, Olga K. Vikulova, Mikhail А. Isakov, Anna V. Zheleznyakova
Publicado 2019

Trends in the epidemiology of chronic kidney disease in Russian Federation according to the Federal Diabetes Register (2013–2016)

por Minara S. Shamkhalova, Olga K. Vikulova, Anna V. Zheleznyakova, Michail A. Isakov, Marina V. Shestakova, Ivan I. Dedov
Publicado 2018